Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
Sales | 0 | 7,562 | 91 | 1,096 | 295 |
Gross Profit | 0 | 7,562 | 91 | 1,096 | 300 |
Operating Expenses | 2,239 | 2,488 | 1,941 | 1,865 | 360 |
Operating Income | -2,239 | 5,074 | -1,850 | -769 | -65 |
Interest Expense | 0 | 0 | 4 | 10 | 8 |
Other Income | 108 | 180 | 110 | 142 | 183 |
Pre-tax Income | -2,131 | 5,254 | -1,743 | -638 | 110 |
Income Tax | N/A | 100 | N/A | 100 | 0 |
Net Income Continuous | -2,131 | 5,154 | -1,743 | -738 | 113 |
Net Income | $-2,131 | $5,154 | $-1,743 | $-738 | $113 |
EPS Basic Total Ops | -6,331.57 | 18,598.98 | -7,123.02 | -3,165.78 | 395.73 |
EPS Basic Continuous Ops | -6,036.17 | 18,549.04 | -7,255.88 | -3,171.54 | 565.00 |
EPS Diluted Total Ops | -5,540.12 | 17,807.54 | -7,123.02 | -3,165.78 | 395.73 |
EPS Diluted Continuous Ops | -5,389.27 | 17,758.70 | -7,255.88 | -3,171.54 | 565.00 |
EBITDA(a) | $-2,172 | $5,099 | $-1,758 | $-697 | $10 |